Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
encorafenib and binimetinib | 1.03 | 1 | 4065 | 87 | 27 |
encorafenib | 0.27 | 1 | 2631 | 52 | 11 |
and | 0.6 | 0.4 | 8692 | 98 | 3 |
binimetinib | 0.65 | 0.9 | 5304 | 38 | 11 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
encorafenib and binimetinib | 1.28 | 0.9 | 4307 | 47 |
encorafenib and binimetinib side effects | 1.11 | 0.2 | 9370 | 13 |
encorafenib and binimetinib spc | 1.33 | 0.9 | 1708 | 3 |
encorafenib and binimetinib nccp | 0.86 | 0.8 | 5461 | 58 |
encorafenib and binimetinib trial | 1.22 | 0.3 | 7954 | 47 |
encorafenib and binimetinib melanoma | 0.04 | 0.9 | 5686 | 48 |
encorafenib and binimetinib swag | 0.25 | 1 | 5390 | 40 |
encorafenib and binimetinib columbus trial | 0.93 | 0.9 | 7331 | 58 |
encorafenib binimetinib melanoma | 1.82 | 0.6 | 6352 | 40 |
encorafenib braftovi + binimetinib mektovi | 0.11 | 0.4 | 3650 | 77 |
encorafenib plus binimetinib | 1.02 | 0.7 | 2603 | 46 |
encorafenib binimetinib side effects | 1.87 | 0.8 | 4610 | 79 |
binimetinib encorafenib cetuximab | 0.06 | 0.1 | 3848 | 100 |
binimetinib + encorafenib | 0.87 | 0.1 | 4379 | 16 |